These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function.
    Author: Thorsen CA, Rossi EC, Green D, Carone FA.
    Journal: Am J Med; 1979 Apr; 66(4):711-6. PubMed ID: 433976.
    Abstract:
    In four patients with clinical and laboratory manifestations of the hemolytic-uremic syndrome, the administration of aspirin and dipyridamole was associated with a dramatic and rapid increase in the platelet count. In three of the four patients there was also improvement in neurologic or renal function. No subject experienced bleeding or other untoward effects. We conclude that a trial of aspirin and dipyridamole therapy is warranted early in the course of the hemolytic-uremic syndrome.
    [Abstract] [Full Text] [Related] [New Search]